$AMRZ

Why is Amrize stock falling today?

Amrize AG shares fell 9.1% to CHF 38.02 after Q2 results missed expectations and the company cut its full-year adjusted EBITDA outlook, citing oil-price driven cost inflation. Q2 EPS was $0.88 vs $0.96 expected, while organic revenue rose 6.7% to $3.5B. Full-year revenue guidance was raised to $12.5B-$12.7B, but adjusted EBITDA was lowered to $3.1B-$3.2B.

Original reporting
Published Aug 7, 2026, 8:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 7, 2026, 8:12 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$AMRZ
Bearish
high confidence
Mentioned
$AMRZ
Relevance
8/10
alphai data visualization · based on investing.com
Decision brief

The 30-second read

$AMRZBearishMed
01

Why it matters

AMRZ’s lowered adjusted EBITDA outlook, despite higher revenue guidance, shifts the risk balance toward margin compression and raises the probability of further estimate revisions.

02

Market read

AMRZ is singled out as the clear outlier among Swiss Market Index components after a quantified guidance reduction tied to cost inflation.

03

What to watch

The article does not quantify how much of the EBITDA miss is recoverable via pricing or cost actions, which could limit downside if margins stabilize.

Relevance 8/10Novelty 7/10Timing: pre-market open context, stock already down ~9% on the day’s earnings and guidance update

Background

The piece frames AMRZ’s drop around a profitability narrative under pressure, citing prior Q1 EPS miss and recurring Building Envelope segment weakness.

Company-level read

Ticker impact

$AMRZBearishHigh confidence
Context

Amrize shares fell 9.1% after Q2 EPS missed and the company cut full-year adjusted EBITDA guidance due to oil-price-driven cost inflation.

Expected impact

Bearish bias for the next several sessions, with elevated volatility as investors reprice profitability risk versus the raised revenue outlook.

Evidence & confidence

The article cites a same-day stock drop tied to specific, quantified guidance revisions (EBITDA range lowered) and a stated segment headwind, which typically drives immediate repricing.

Market effects

Reinforces investor sensitivity to margin durability in building envelope and weatherization-related product demand when input costs rise.

Swiss Market Index components show AMRZ as the outlier decliner, suggesting idiosyncratic rather than broad index pressure.

Oil-price-driven cost inflation narrative can spill over to other cost-sensitive industrials, but the article’s catalyst is company-specific.

Counterpoint

The company raised full-year revenue guidance, so the market may be over-penalizing temporary cost inflation versus longer-term demand and pricing power.

Key entities

  • Amrize AG

    Swiss-listed company whose Q2 results missed EPS and whose full-year adjusted EBITDA outlook was cut, driving a sharp share decline.

  • Building Envelope segment

    Roofing, insulation, and weatherization products segment described as a persistent margin drag due to volume softness.

  • U.S. jobs report

    Macro catalyst mentioned as part of the broader market setup ahead of the open.

Related articles

MedAI 8/10

Why is Amrize stock sliding today?

Amrize AG shares fell about 9.1% to around 38 after the company reported Q2 2026 results. EPS was $0.88 vs $0.96 expected, while revenue was $3.5B vs $3.35B expected. Amrize cut full-year adjusted EBITDA guidance, citing higher costs linked to elevated oil prices, driving the selloff.

$AMRZHighAI 9/10

Amrize Reports Second Quarter 2026 Results

Amrize (AMRZ) reported Q2 2026 revenues of $3,494 million, up 8.6% year over year, with net income rising 14.4% to $476 million and adjusted EBITDA up 5.8% to $986 million. The company returned $502 million via buybacks and dividends and raised FY 2026 guidance, citing demand and oil-price driven cost inflation. Capex was $241 million in the quarter.

$AMRZHigh

Amrize Ltd (AMRZ): Results of Operations and Financial Condition

Amrize Ltd (AMRZ) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 amrizeq22026pressrelease.htm EX-99.1 amrizeq22026pressrelease Amrize Reports Second Quarter 2026 Results • Revenues up 8.6% with organic growth of 6.7% on strong demand and pricing • Net Income increased 14.4% to $476 million and Adjusted EBITDA grew 5.8% to $986 millio

$AMRZMed

Why is Amrize stock sliding today? By Investing.com

Investing.com reports Amrize AG shares fell 5.8% to $50.87 after Truist Securities analyst Keith Hughes downgraded the stock from Buy to Hold and cut the price target from $65 to $48. The target is below InvestingPro’s fair value ($56.69) and near the 52-week low ($44.12), following Q1 2026 earnings miss and segment volume softness.